SU439965A3 - The method of obtaining aryl-2-aminoalkoxy - Google Patents

The method of obtaining aryl-2-aminoalkoxy

Info

Publication number
SU439965A3
SU439965A3 SU1700804A SU1700804A SU439965A3 SU 439965 A3 SU439965 A3 SU 439965A3 SU 1700804 A SU1700804 A SU 1700804A SU 1700804 A SU1700804 A SU 1700804A SU 439965 A3 SU439965 A3 SU 439965A3
Authority
SU
USSR - Soviet Union
Prior art keywords
aminoalkoxy
obtaining aryl
aryl
obtaining
Prior art date
Application number
SU1700804A
Other languages
Russian (ru)
Other versions
SU439965A1 (en
Inventor
Эрих Мюллер
Роланд Майер
Вилли Дидерен
Original Assignee
Д-Р Карл Томэ Гмбх (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Д-Р Карл Томэ Гмбх (Фирма) filed Critical Д-Р Карл Томэ Гмбх (Фирма)
Application granted granted Critical
Publication of SU439965A3 publication Critical patent/SU439965A3/en
Publication of SU439965A1 publication Critical patent/SU439965A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/18Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring
    • C07C39/19Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring containing carbon-to-carbon double bonds but no carbon-to-carbon triple bonds
    • C07C39/20Hydroxy-styrenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/42Singly bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056Esters of arylalkanephosphonic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Illuminated Signs And Luminous Advertising (AREA)
SU1700804A 1970-07-28 Method for producing aryl-2-aminoalkoxy histilols SU439965A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1939809A DE1939809B2 (en) 1969-08-05 1969-08-05 β-Aryl-2-aminoalkoxy-styrenes and process for their preparation

Publications (2)

Publication Number Publication Date
SU439965A3 true SU439965A3 (en) 1974-08-15
SU439965A1 SU439965A1 (en) 1974-08-15

Family

ID=

Also Published As

Publication number Publication date
CH548983A (en) 1974-05-15
RO57794A (en) 1975-06-15
IE34634B1 (en) 1975-07-09
SU428597A3 (en) 1974-05-15
FI54912B (en) 1978-12-29
SU432712A3 (en) 1974-06-15
CH548367A (en) 1974-04-30
RO58837A (en) 1975-09-15
RO57548A (en) 1975-02-15
BG17952A3 (en) 1974-03-05
AT302346B (en) 1972-10-10
BG18599A3 (en) 1975-02-25
NO135243B (en) 1976-11-29
ES382430A1 (en) 1972-12-01
CS170536B2 (en) 1976-08-27
CS170535B2 (en) 1976-08-27
YU198170A (en) 1979-07-10
JPS5113147B1 (en) 1976-04-26
KR780000113B1 (en) 1978-04-15
ES382427A1 (en) 1972-11-16
PL93130B1 (en) 1977-05-30
NL7011590A (en) 1971-02-09
CS170533B2 (en) 1976-08-27
ES382425A1 (en) 1972-11-16
FR2068463B1 (en) 1974-08-30
CH548366A (en) 1974-04-30
RO58861A2 (en) 1975-06-30
RO57793A (en) 1975-03-15
BG17950A3 (en) 1974-03-05
CS170537B2 (en) 1976-08-27
GB1307436A (en) 1973-02-21
BG20095A3 (en) 1975-10-30
JPS5113149B1 (en) 1976-04-26
PL78370B1 (en) 1975-06-30
HU163185B (en) 1973-06-28
IE34634L (en) 1971-02-05
CH548981A (en) 1974-05-15
ES382429A1 (en) 1972-11-16
IL35047A0 (en) 1970-10-30
JPS5113148B1 (en) 1976-04-26
SU450398A3 (en) 1974-11-15
CS170538B2 (en) 1976-08-27
FI54912C (en) 1979-04-10
AT303055B (en) 1972-11-10
YU37478A (en) 1979-07-10
FR2068463A1 (en) 1971-08-27
JPS4941433B1 (en) 1974-11-08
ES382428A1 (en) 1972-11-16
BE754405A (en) 1971-02-04
SU439966A3 (en) 1974-08-15
ES382426A1 (en) 1972-11-16
JPS5113150B1 (en) 1976-04-26
IL35047A (en) 1973-05-31
AT302345B (en) 1972-10-10
AT301565B (en) 1972-09-11
JPS5113146B1 (en) 1976-04-26
DK139717C (en) 1979-09-17
BG17951A3 (en) 1974-03-05
CH548368A (en) 1974-04-30
ZA705411B (en) 1971-05-27
DE1939809C3 (en) 1979-01-11
DE1939809B2 (en) 1978-04-13
CH548982A (en) 1974-05-15
NO135243C (en) 1977-03-09
SE382211B (en) 1976-01-19
BG18600A3 (en) 1975-02-25
DE1939809A1 (en) 1971-02-18
CS170534B2 (en) 1976-08-27
AT302344B (en) 1972-10-10
DK139717B (en) 1979-04-02
PH9520A (en) 1976-01-09

Similar Documents

Publication Publication Date Title
BG18599A3 (en) METHOD FOR THE PREPARATION OF BETA-ARYL-2-AMINOALKOXYSTYROLES
BG17749A3 (en) METHOD FOR THE PREPARATION OF PHENOXY-2-HYDROXY -3- CYCLOALKYLAMINOPROPANES
BG17956A3 (en) METHOD FOR OBTAINING NIPHTHYLAL-KILAMINES
BG18603A3 (en) METHOD FOR THE CONTINUOUS PREPARATION OF CYCLOHEXANONOXIME
SU437302A3 (en) The method of obtaining arylphenylmethylchlorosilanes
BG17534A3 (en) METHOD FOR OBTAINING NEW AMINOPROPIOPHENONES
SU439986A3 (en) The method of obtaining derivatives tiepina
SU438178A3 (en) The method of obtaining-isopropylaniline
BG17973A3 (en) METHOD FOR OBTAINING TETRAHYDRO-BENZIADIAZEPINONES
BG17531A3 (en) METHOD FOR OBTAINING ALKYLAMINOPROPANES
BG17536A3 (en) METHOD FOR OBTAINING SUBSTITUTED CYLANILIDES
SU439994A3 (en) The method of obtaining 11-deacetoxy-wortmannin
SU446962A3 (en) The method of obtaining trichlorethylene
SU439969A3 (en) The method of obtaining substituted benzenesulfonylurea
SU437284A3 (en) The method of obtaining derivatives of indeno-pyridine
BG17306A3 (en) METHOD FOR OBTAINING NEW CARDENOLIDE-GLYCOSIDES
BG16185A3 (en) METHOD FOR THE PREPARATION OF 1-ALKYL-2-AMINOMETHYLPYROLDINES
SU441708A3 (en) The method of obtaining 10-methoxyazmalicin
SU438180A3 (en) The method of obtaining phenylthiocarbamate
SU439963A3 (en) The method of obtaining phenylaminoalkanes
SU441707A3 (en) The method of obtaining derivatives of isoquinoline
BG17817A3 (en) METHOD OF PREPARING POLYTEREPTHALOYL-XALAMIDRAZONE
BG16325A3 (en) METHOD FOR OBTAINING GAMMA-CYANOBUTYRALDEHYDE
BG17758A3 (en) METHOD FOR OBTAINING NAPHTYLALKYLAMINES
SU439968A3 (en) The method of producing polypeptides